Vascularization of liver tumors – Preliminary results with Coded Harmonic Angio (CHA), phase inversion imaging, 3D power Doppler and contrast medium-enhanced B-flow with second generation contrast agent (Optison®)
Affiliations: Department of Radiology, Passau Hospital, Germany | Department of Radiology, Homburg/Saar University Hospital, Germany | Department of Radiology, Brig Hospital, Switzerland | University of Saarbrücken, Germany | Department of Radiology, Regensburg University Hospital, Germany
Note: [] Corresponding author: Ernst Michael Jung, MD, Department of Diagnostic Radiology, Passau Hospital, Innstr. 76, D-94032 Passau, Germany. Tel.: +49 851 5300 2366; Fax: +49 851 5300 2202; E-mail: emjung@web.de.
Abstract: Purpose: To investigate the dynamic value of contrast medium-enhanced ultrasonography with Optison® for appraisal of the vascularization of hepatic tumors using harmonic imaging, 3D-/power Doppler and B-flow. Materials/methods: 60 patients with a mean age of 56 years (range 35–76 years) with 93 liver tumors, including histopathologically proven hepatocellular carcinoma (HCC) [15 cases with 20 lesions], liver metastases of colorectal tumors [17 cases with 33 lesions], metastases of breast cancer [10 cases with 21 lesions] and hemangiomas [10 cases with 19 lesions] were prospectively investigated by means of multislice CT as well as native and contrast medium-enhanced ultrasound using a multifrequency transducer (2.5–4 MHz, Logig 9, GE). B scan was performed with additional color and power Doppler, followed by a bolus injection of 0.5 ml Optison®. Tumor vascularization was evaluated with coded harmonic angio (CHA), pulse inversion imaging with power Doppler, 3D power Doppler and in the late phase (>5 min) with B-flow. In 15 cases with HCC, i.a. DSA was performed in addition. The results were also correlated with MRT and histological findings. Results: Compared to spiral-CT/MRT, only 72/93 (77%) of the lesions could be detected in the B scan, 75/93 (81%) with CHA and 93/93 (100%) in the pulse inversion mode. Tumor vascularization was detectable in 43/93 (46%) of lesions with native power Doppler, in 75/93 (81%) of lesions after administering contrast medium in the CHA mode, in 81/93 (87%) of lesions in the pulse inversion mode with power Doppler and in 77/93 (83%) of lesions with contrast-enhanced B-flow. Early arterial and capillary perfusion was best detected with CHA, particularly in 20/20 (100%) of the HCC lesions, allowing a 3D reconstruction. 3D power Doppler was especially useful in investigating the tumor margins. Up to 20 min after contrast medium injection, B-flow was capable of detecting increased metastatic tumor vascularization in 42/54 (78%) of cases and intratumoral perfusion in 17/20 (85%) of HCC cases. All 19 hemangiomas were correctly classified by phase inversion imaging. Conclusions: Contrast medium-enhanced ultrasound investigation of liver tumors with Optison® allowed reliable detection of tumor foci and, in most cases, appraisal of tumor vascularization. The time available for evaluation of tumor margin vascularization was substantially longer in B-flow.
Keywords: Liver tumors, vascularization, contrast medium-enhanced ultrasound, 3D imaging
